Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
8.72
+0.13 (1.51%)
Apr 15, 2026, 2:00 PM EDT - Market open
Xilio Therapeutics Employees
Xilio Therapeutics had 76 employees as of December 31, 2025. The number of employees increased by 12 or 18.75% compared to the previous year.
Employees
76
Change (1Y)
12
Growth (1Y)
18.75%
Revenue / Employee
$575,868
Profits / Employee
-$461,000
Market Cap
50.42M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 76 | 12 | 18.75% |
| Dec 31, 2024 | 64 | -9 | -12.33% |
| Mar 31, 2024 | 56 | -33 | -37.08% |
| Dec 31, 2023 | 73 | -16 | -17.98% |
| Sep 30, 2023 | 81 | -8 | -8.99% |
| Jun 30, 2023 | 84 | 6 | 7.69% |
| Mar 31, 2023 | 89 | 11 | 14.10% |
| Dec 31, 2022 | 89 | 15 | 20.27% |
| Mar 31, 2022 | 78 | 21 | 36.84% |
| Dec 31, 2021 | 74 | 17 | 29.82% |
| Sep 30, 2021 | 69 | - | - |
| Jun 30, 2021 | 66 | - | - |
| Mar 31, 2021 | 57 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Metagenomi Therapeutics | 119 |
| Mereo BioPharma Group | 39 |
| Cue Biopharma | 29 |
| Entera Bio | 22 |
| Lisata Therapeutics | 21 |
| RenovoRx | 17 |
| Edesa Biotech | 17 |
| Atossa Therapeutics | 16 |
XLO News
- 11 days ago - Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 23 days ago - Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire
- 4 weeks ago - Xilio Therapeutics Announces 1-for-14 Reverse Stock Split - GlobeNewsWire
- 6 weeks ago - Xilio Therapeutics to Present at the Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Xilio Therapeutics Announces Pricing of Underwritten Offering - GlobeNewsWire
- 3 months ago - Xilio Therapeutics Highlights Upcoming Milestones and Recent Corporate Updates - GlobeNewsWire
- 5 months ago - Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results - GlobeNewsWire